65,437 trials
Dental Pain
Primary: Total Pain Relief at 6 Hours Post Dose (TOTPAR 6) — 2.45; 4.37 units on a scale
Stage II Peripheral Arterial Occlusive Disease · Intermittent Claudication Fontaine Stage II PAOD
Primary: Ratio of Pain-free Walking Distance After Period 2 in Comparison With the Findings at Baseline — 2.60; 1.98 meter/meter
Acute Bipolar Depression
Primary: Change in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score. — 23.7; 24.3 scores on a scale
Ankylosing Spondylitis
Primary: Assessment of Ankylosing Spondylitis Response (ASAS 20) at Week 14 — 26; 53 Participants
Osteoarthritis
Primary: Joint Space Width (JSW) in the Medial Tibiofemoral Knee Joint in Signal Knee Measured by X-ray After 24 Months. — -0.188; -0.198 mm
Multiple Myeloma
Primary: Maximum Tolerated Dose (MTD) of IPH2101 as Determined by Number of Participants With Dose-Limiting Toxicities (DLTs) Related to IPH2101 Treatment — 0; 0; 0; 1 Number of…
Obesity
Primary: BMI Z-score(for Gender and Age)at 6-months — -0.129; 0.001 Z-score
Erectile Dysfunction
Primary: Change in Percentage of Sexual Attempts in Which Subjects Are Able to Maintain an Erection of Sufficient Duration to Have Successful Intercourse — 13.9; 28.0; 29.4…
Biological Availability
Primary: Area Under the Curve From Time Zero to Extrapolated Infinite Time [AUC (0 - ∞)] — 1286.00; 1204.00; 1180.00 ng*hr/mL
Erectile Dysfunction
Primary: Change in Percentage of Sexual Attempts in Which Subjects Were Able to Maintain an Erection of Sufficient Duration to Have Successful Intercourse — 13.6; 28.7; 34.0…
Postmenopause
Primary: Number of Participants in the DRSP/E2 Group With an Assessment of Endometrial Hyperplasia or Worse at End of Study (EoS) (1 Year of Treatment) — 0 Participants
Erectile Dysfunction
Primary: Change in Percentage of Sexual Attempts in Which Subjects Were Able to Maintain an Erection of Sufficient Duration to Have Successful Intercourse. — 54.75 percentage of…
QIAGEN ResPlex II Advanced Panel · Influenza A · Respiratory Syncytial Virus Infections
Primary: Detection of Respiratory Viruses — 83 participants
Influenza
Primary: Haemagglutination Inhibition (HI) Antibody Titers Against H1N1 in All Subjects Receiving Fluarix Vaccine — 120.7; 1079.3 titer
Healthy
Primary: Computer Based Objective Cognition Testing (CogState) Detection Speed — 2.6333; 2.5971; 2.6103; 2.5842 Log10 MS